{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T20:39:59Z","timestamp":1779136799535,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jbspin.2015.08.008","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T06:32:23Z","timestamp":1444890743000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Vaccinations in adults with chronic inflammatory joint disease: Immunization schedule and recommendations for patients taking synthetic or biological disease-modifying antirheumatic drugs"],"prefix":"10.1016","volume":"83","author":[{"given":"Jacques","family":"Morel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine Guillaume","family":"Czitrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auriane","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9mie","family":"Sellam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Sibilia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2015.08.008_bib0275","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0280","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/ard.2011.151043","article-title":"Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?","volume":"70","author":"Strangfeld","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0285","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/annrheumdis-2013-203341","article-title":"Evaluation of the RABBIT Risk Score for serious infections","volume":"73","author":"Zink","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0290","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrrheum.2014.206","article-title":"Vaccination of patients with autoimmune inflammatory rheumatic diseases","volume":"11","author":"Westra","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0295","first-page":"S1","article-title":"Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Societe Fran\u00e7aise de Rhumatologie, SFR)","volume":"72","author":"Pham","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0300","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0305","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jbspin.2013.09.001","article-title":"Recommendations for using TNFalpha antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health","volume":"80","author":"Goeb","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0310","series-title":"Le Calendrier des vaccinations et les recommandations vaccinales 2013 selon l\u2019avis du Haut Conseil de la sant\u00e9 publique","author":"InVs","year":"2013"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0315","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1002\/art.20616","article-title":"Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection","volume":"50","author":"Tam","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0320","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"Clinical Practice Guidelines: management of chronic hepatitis","volume":"50","author":"EASL","year":"2009","journal-title":"Brit J Hepatol"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0325","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jbspin.2014.01.015","article-title":"Systemic diseases and biotherapies: understanding, evaluating, and preventing the risk of hepatitis B reactivation","volume":"81","author":"Lunel-Fabiani","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0330","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/17402520600589613","article-title":"Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis","volume":"13","author":"Elkayam","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0335","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/ajg.2012.79","article-title":"Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease","volume":"107","author":"Gisbert","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0340","series-title":"Recommandations sanitaires pour les voyageurs","author":"InVs","year":"2011"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0345","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tmaid.2014.01.005","article-title":"Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre study","volume":"12","author":"Askling","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0350","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jbspin.2013.07.009","article-title":"Risk of herpes\/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis","volume":"81","author":"Che","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0355","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0360","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2012.7304","article-title":"Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases","volume":"308","author":"Zhang","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0365","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.38960","article-title":"Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever","volume":"67","author":"Oliveira","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0370","series-title":"Assesment report-Prevenar 13","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0375","doi-asserted-by":"crossref","first-page":"e94681","DOI":"10.1371\/journal.pone.0094681","article-title":"Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005\u20132009","volume":"9","author":"Ntshoe","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0380","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.vaccine.2006.11.032","article-title":"Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998\u20132006)","volume":"25","author":"Oosterhuis-Kafeja","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0385","series-title":"FDA expands use of Prevnar 13 vaccine for people aged 50 and older","author":"Food and Drug Administration","year":"2011"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0390","series-title":"Recommandations vaccinales sp\u00e9cifiques des personnes immunod\u00e9prim\u00e9es ou aspl\u00e9niques","author":"Haut Conseil de la Sant\u00e9 Publique","year":"2012"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0395","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/ar4127","article-title":"Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs","volume":"15","author":"Crnkic Kapetanovic","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0400","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/acr.20465","article-title":"Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases","volume":"63","author":"Elkayam","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0405","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4161\/hv.22550","article-title":"Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study","volume":"9","author":"Mahamat","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0410","first-page":"S163","article-title":"The risk of pneumococcal infections after immunisation with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients","volume":"65","author":"Bengtsson","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0415","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/ard.2005.036434","article-title":"Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers","volume":"65","author":"Fomin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0420","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1136\/ard.2011.152983","article-title":"Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice","volume":"70","author":"Ribeiro","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0425","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/art.30325","article-title":"Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study","volume":"63","author":"Gabay","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0430","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.semarthrit.2008.12.002","article-title":"The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"39","author":"Elkayam","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0435","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/s10165-007-0632-5","article-title":"Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis","volume":"17","author":"Kubota","year":"2007","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0440","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/acr.22246","article-title":"Effect of methotrexate, anti-tumor necrosis factor alpha, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"66","author":"Hua","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0445","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.rhum.2007.10.072","article-title":"\u00c9tude de la r\u00e9ponse immunitaire au vaccin antigrippal chez les patients ayant une polyarthrite rhumato\u00efde et trait\u00e9s par abatacept","volume":"74","author":"Schaeverbeke","year":"2007","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0450","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/acr.21838","article-title":"Abatacept and reduced immune response to pandemic 2009 influenza A\/H1N1 vaccination in patients with rheumatoid arthritis","volume":"65","author":"Ribeiro","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0455","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1136\/annrheumdis-2012-201950","article-title":"Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis","volume":"71","author":"Mori","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0460","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1186\/ar4358","article-title":"Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis","volume":"15","author":"Crnkic Kapetanovic","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0465","doi-asserted-by":"crossref","first-page":"A579","DOI":"10.1136\/annrheumdis-2013-eular.1727","article-title":"Antibody response to pneumococcal and influenza vaccination in patients with ra receiving subcutaneous abatacept","volume":"72","author":"Alten","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0470","article-title":"Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)","author":"Bingham","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0475","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/ard.62.7.685","article-title":"Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis","volume":"62","author":"Bridges","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0480","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2474-8-58","article-title":"An audit of influenza and pneumococcal vaccination in rheumatology outpatients","volume":"8","author":"Sowden","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0485","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/ard.2006.060285","article-title":"Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis","volume":"66","author":"Pradeep","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0490","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/ard.2007.081703","article-title":"Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease","volume":"67","author":"Lanternier","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0495","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10067-008-1024-8","article-title":"Preventive influenza vaccination for patients with rheumatoid arthritis. A need for an international campaign","volume":"28","author":"Koutsogeorgopoulou","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0500","first-page":"208","article-title":"Influenza and pneumococcal vaccination and varicella status in inflammatory arthritis patients","volume":"104","author":"McCarthy","year":"2011","journal-title":"Ir Med J"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0505","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/rheumatology\/keq297","article-title":"Routinely measuring and reporting pneumococcal vaccination among immunosuppressed rheumatology outpatients: the first step in improving quality","volume":"50","author":"Desai","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0510","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jbspin.2010.10.012","article-title":"The uptake of influenza and pneumococcal vaccination among immunocompromised patients attending rheumatology outpatient clinics","volume":"78","author":"Haroon","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0515","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00296-011-1808-z","article-title":"Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study","volume":"32","author":"Feuchtenberger","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0520","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.rhum.2015.02.004","article-title":"Couverture vaccinale contre la grippe et le pneumocoque \u00e0 partir de 584 patients atteints de Rhumatisme Chronique Inflammatoire et trait\u00e9s par biom\u00e9dicaments dans le sud-est de la France","volume":"82","author":"Brocq","year":"2015","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0525","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/rheumatology\/keu531","article-title":"Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients","volume":"54","author":"Hua","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0530","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1136\/annrheumdis-2013-204733","article-title":"Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA)","volume":"74","author":"Dougados","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0535","first-page":"1469","article-title":"Why have rheumatologists been reluctant to vaccinate patients with systemic lupus erythematosus?","volume":"33","author":"Mercado","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.08.008_bib0540","first-page":"859","article-title":"[Hepatitis B vaccination and serious side-effects: sequence is not consequence]","volume":"25","author":"Cales","year":"2001","journal-title":"Gastroenterol Clin Biol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15001797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15001797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T20:22:35Z","timestamp":1537302155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X15001797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1297319X15001797"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.08.008","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccinations in adults with chronic inflammatory joint disease: Immunization schedule and recommendations for patients taking synthetic or biological disease-modifying antirheumatic drugs","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}